Literature DB >> 26135770

Ischemia-modified albumin as an oxidative stress biomarker in early pregnancy loss.

Huseyin Cengiz1, Hediye Dagdeviren1, Ammar Kanawati1, Sema Suzen Çaypinar1, Ali Yesil1, Murat Ekin1, Levent Yasar1.   

Abstract

BACKGROUND/AIMS: This study aimed to determine the association between early pregnancy loss and serum ischemia-modified albumin (IMA) concentrations.
METHODS: Serum samples of 180 women that included healthy pregnant women, women admitted for termination of pregnancy due to the absence of fetal cardiac activity or absence of fetal pole on ultrasonographic examination, and healthy non-pregnant women attending for gynecological examination. Each group included 60 patients. Serum concentrations of IMA were compared among the groups, and the correlations with patients' age, gravidity, BMI, gestational age and total serum albumin concentrations were calculated.
RESULTS: When the groups were compared with respect to IMA concentrations, the group with early pregnancy loss was found to have significantly higher IMA concentrations (p < 0.001). An IMA threshold of >163 ng/mL had a sensitivity of 75%, specificity of 55% to discriminate between healthy pregnant patients and patients with early pregnancy loss in first trimester.
CONCLUSION: Our findings support the theory that possible oxidative stress, a more hypoxic environment and defective placentation lead to increased serum IMA concentrations. These findings may help to shed light on the complicated pathogenesis of early pregnancy loss.

Entities:  

Keywords:  Defective placentation; early pregnancy loss; ischemia-modified albumin; oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 26135770     DOI: 10.3109/14767058.2015.1061494

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

Review 1.  Ischemia-Modified Albumin: Origins and Clinical Implications.

Authors:  Alla Shevtsova; Iuliia Gordiienko; Viktoriia Tkachenko; Galyna Ushakova
Journal:  Dis Markers       Date:  2021-07-19       Impact factor: 3.434

2.  Biomarkers of Uremic Cardiotoxicity.

Authors:  Bojan Stopic; Sandra Dragicevic; Branislava Medic-Brkic; Aleksandra Nikolic; Marko Stojanovic; Sreten Budisavljevic; Nada Dimkovic
Journal:  Toxins (Basel)       Date:  2021-09-10       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.